Cite
HARVARD Citation
Westhovens, R. et al. (n.d.). AB0491 Fatigue is an independent variable predicting physical function and DAS-28 remission for patients with rheumatoid arthritis treated with intravenously administered golimumab: results from phase 3, placebo controlled clinical trial. Annals of the rheumatic diseases. p. 665. [Online].